Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
General Session Abstracts

Abstract S5-06: Large-scale identification of cell-specific PARP substrates

Yonghao Yu and Yajie Zhang
Yonghao Yu
UT Southwestern Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yajie Zhang
UT Southwestern Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.SABCS14-S5-06 Published May 2015
  • Article
  • Info & Metrics
Loading
Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX

Abstract

PARPs (poly-ADP-ribose polymerases) catalyze a protein posttranslational modification termed Poly-ADP-ribosylation (PARylation). PARylation is composed of linear and/or branched repeats of ADP-ribose, whose lengths can reach up to 200 units. The first gene encoding a poly-ADP-ribose polymerase, PARP1, was cloned in 1987. Numerous efforts have now led to the identification of 16 additional PARP enzymes.

PARP1 is a nuclear protein that is activated as a result of sensing DNA strand breaks. PARylation levels in a quiescent cell are usually very low. In response to genotoxic stress, PARP1 is recruited to nicked DNA and is rapidly activated. This triggers the synthesis of a large number of PARylated proteins and the initiation of DNA damage repair mechanisms. Cancer cells with defects in double-strand break (DSB) repair, such as BRCA1/2-mutated cells, are reliant on PARP1 activity for genome integrity. These cells undergo unsustainable genetic damage, and eventually, apoptosis upon PARP1 inhibition. Indeed, recent late-stage clinical studies revealed that PARP1 inhibitor treatment significantly prolonged progression-free survival of BRCA-deficient breast cancer patients.

Contrary to the fruitful efforts in characterizing the upstream inputs regulating PARP1, its genuine downstream targets, however, remain poorly defined. We recently developed the first mass spectrometry-based approach to a global mapping of the human aspartic acid- and glutamic acid-ADP-ribosylated proteome (Zhang et al., Nature Methods 2013). This method allowed us to identify 1,048 in vivo PARylation sites on 340 proteins. These modified proteins are involved in a wide array of nuclear functions including DNA damage repair, transcription regulation, epigenetic modulation, and mRNA processing. Using a quantitative mass spectrometry experiment, we also identified hundreds of novel PARP1 downstream effectors.

The central hypothesis of our current study is that ADP-ribosylation levels of PARP1 substrates can reflect the activity of PARP1 in a cell. We predict that a signature composed of multiple PARylated proteins can then be used to identify cells that are "addicted" to PARP1 activity for genome integrity. To this end, we performed a large scale profiling of the Asp- and Glu-ADP-ribosylated proteome of a benign breast epithelial cell line (MCF10A), and compared it to that of a panel of eight breast carcinoma cell lines, including the ER+ (MCF7, T47D and ZR-75-1), HER2+ (SKBR3), and triple negative (MDA-MB-231, MDA-MB-468, SUM159 and HCC1937) subtypes. Among these lines, MDA-MB-468 (PTEN null), SKBR3 (HER2+) and HCC1937 (BRCA1 null) are known to be sensitive to PARP inhibitors. We correlated the pattern of protein ADP-ribosylation to their IC50, and found events of predictive value. In addition, we also observed that the differential PARylation pattern among these cells can be divided into a "public" (proteins that are commonly modified across all cell lines) class, and a "private" one (proteins that specifically modified in certain cell lines). We envision that this dataset will also serve as a valuable resource for the PARP1/DNA damage research community to investigate cell line-specific Asp- and Glu-ADP-ribosylation events.

Citation Format: Yonghao Yu, Yajie Zhang. Large-scale identification of cell-specific PARP substrates [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr S5-06.

Previous
Back to top
Cancer Research: 75 (9 Supplement)
May 2015
Volume 75, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract S5-06: Large-scale identification of cell-specific PARP substrates
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract S5-06: Large-scale identification of cell-specific PARP substrates
Yonghao Yu and Yajie Zhang
Cancer Res May 1 2015 (75) (9 Supplement) S5-06; DOI: 10.1158/1538-7445.SABCS14-S5-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract S5-06: Large-scale identification of cell-specific PARP substrates
Yonghao Yu and Yajie Zhang
Cancer Res May 1 2015 (75) (9 Supplement) S5-06; DOI: 10.1158/1538-7445.SABCS14-S5-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

General Session Abstracts

  • Abstract GS5-01: Appropriate margins for breast conserving surgery in patients with early stage breast cancer: A meta-analysis
  • Abstract GS5-07: Weight change in postmenopausal women and breast cancer risk in the women's health initiative observational study
  • Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
Show more 3

General Session 5

  • Abstract GS5-01: Appropriate margins for breast conserving surgery in patients with early stage breast cancer: A meta-analysis
  • Abstract GS5-07: Weight change in postmenopausal women and breast cancer risk in the women's health initiative observational study
  • Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement